Navigation Links
Invasion of the brain tumors
Date:8/13/2007

Gliomas are highly malignant and invasive tumors with tendrils that extend far from the primary tumor site, rendering conventional therapies ineffective and leading to an invariably poor prognosis. In a new study published online this week in the open-access journal PLoS Biology, Angela Johnston, Donna Senger, and colleagues at the University of Calgary injected immunocompromised mice with human gliomas and compared invasive cells (which left the primary tumor site) to noninvasive cells (which remained at the site of injection) in order to understand the molecular mechanisms underlying this invasive behavior. They identified the neurotrophin receptor p75NTR, which normally functions during development to induce neurite outgrowth and promote neuronal cell death, as an important regulator of glioma invasion. The researchers present the first evidence that this neurotrophin receptor can also be a potent mediator of glioma invasion, and they show that the expression of this receptor is sufficient to impart a dramatic invasive behavior on genetically distinct tumors. These data highlight a previously unknown function of this receptor and suggest it may be a novel therapeutic target in the treatment of this devastating cancer.


'/>"/>

Contact: Natalie Bouaravong
press@plos.org
415-568-3445
Public Library of Science
Source:Eurekalert

Page: 1

Related biology news :

1. Chimp genome reveals a retroviral invasion
2. Gene expands malarias invasion options
3. Researchers identify molecular anchor that allows bacterial invasion of central nervous system
4. Exotic crab poised for widespread UK invasion
5. Different strategies underlie the ecology of microbial invasions
6. Whiteflies and plant viruses can help each other to speed up biological invasion
7. Invasion of the island bats
8. Controversial drug shown to act on brain protein to cut alcohol use
9. Drug That Tags Decision-making Areas Of The Brain May Aid
10. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
11. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015 To bolster its efforts ... HYPR Corp. announced today the addition of two new team ... as board advisor and David Raviv will act ... underscore HYPR Corp.,s commitment to providing the most secure solutions ... Sirota co-founded Layer 7 Technologies, a provider of security ...
(Date:6/29/2015)... DUBLIN , June 24, 2015 ... the addition of the "Latin America Biomedical Sensors ... to their offering. The Latin America Biomedical ... at a CAGR of 2.04% over the period 2014-2020 ... that are adaptable to the genetic formulation of each ...
(Date:6/25/2015)... June 25, 2015 According ... Type (Swipe & Area), Technology, Material (Optical Prism, ... Commercial Security & Others) & Geography - Global ... the said market is expected to reach $14,500.07 ... Browse 76 market Tables and ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4
... available in German . , In emerging ... dramatically. Indeed, worldwide consumption of red meat has quadrupled since ... increasing prosperity to lead to a doubling of global meat ... planet, with its limited farmland resources, will still be able ...
... international team of researchers led by Daniel J. ... for Translational Medicine and Therapeutics, has received a ... to study the molecular genetics of atherosclerotic cardiovascular ... Genes Associated with Plasma Lipids and Cardiovascular Disease," ...
... equity fund that specializes in making concentrated investments ... is co-managed by Philip Sassower, CEO, and Andrea ... Chairman and CEO, while Mr. Goren is the ... StatementsCertain statements contained in this press release, including ...
Cached Biology News:Eating low-fat, thanks to lupin proteins 2Penn Medicine researcher receives $6 million grant for cardiovascular disease study 2
(Date:7/29/2015)... , July 30, 2015 ... reports results for the second quarter of 2015. ... group,s results and its performance in different businesses. ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics ... Q2 results - Performance drivers ...
(Date:7/29/2015)... 2015 US-Australian drug discovery company, Novogen Limited ... is committed to progressing its ground-breaking technology platforms to ... to ensure the Company delivers the best value for ... Ross , said the Company currently had an extensive ... discovery programs and academic partnerships and initiatives, and he ...
(Date:7/29/2015)... July 29, 2015  HealthSouth Corporation (NYSE: ... providers of post-acute healthcare services, offering both facility-based ... of operations for the second quarter ended June 30, ... characterized by strong volume growth in both segments ... said Jay Grinney, President and Chief Executive Officer ...
(Date:7/29/2015)... 29, 2015 Research ... addition of the "Global Biosimilars Market, 2015 ... The Global Biosimilars Market, 2015 - 2025, ... growing biosimilars market. With the blockbuster biologics losing ... costs, biosimilars are being viewed as viable substitutes ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17HealthSouth Reports Results for Second Quarter 2015 18HealthSouth Reports Results for Second Quarter 2015 19HealthSouth Reports Results for Second Quarter 2015 20HealthSouth Reports Results for Second Quarter 2015 21HealthSouth Reports Results for Second Quarter 2015 22HealthSouth Reports Results for Second Quarter 2015 23HealthSouth Reports Results for Second Quarter 2015 24HealthSouth Reports Results for Second Quarter 2015 25HealthSouth Reports Results for Second Quarter 2015 26HealthSouth Reports Results for Second Quarter 2015 27
... ECM Solution Available to Healthcare Organizations through CSC,s ... ... Va., June 11 CSC (NYSE: CSC ) today,announced ... through the company,s FirstPortfolio offering.,FirstPoint streamlines a health organization,s document ...
... 10 BioSpecifics,Technologies Corp. (OTC BB BSTC.OB-News) today ... shares of its common stock priced at $15,per ... The shares,were purchased by certain private investors on ... company managed PIPE transaction at a premium over ...
... KV Pharmaceutical Company,(NYSE: KVa/KVb), a fully integrated ... markets technology-differentiated,branded products and generic/non-branded prescription pharmaceuticals,today ... litigation filed by a smaller,generic drug company, ... with PrimaCare ONE(R), a prenatal vitamin product ...
Cached Biology Technology:CSC Adds Content Management to Hosted Healthcare Offering 2KV Pharmaceutical Company Comments on Legal Development in Its Branded Pharmaceutical Business 2KV Pharmaceutical Company Comments on Legal Development in Its Branded Pharmaceutical Business 3
... for immune complex disruption (ICD) of antigen/antibody ... a combination of low pH and heat. ... to microplate wells which are coated with ... HIV-1 p24. The immobilized monoclonal antibody captures ...
... this kit are prepared with pure chemicals ... Mitochondria Isolation Kit is designed to isolating ... and easy way. One kit is consisted ... (enriching mitochondria from 10 20 g ...
... Pipette Tracker is an automated solution ... calibration and performance testing for all pipettes ... directly from any balance Supports ... ISO 8655, DIN 12650, ISO 9000, NCCLS ...
... Tecans new Enzyme-Linked Immunosorbent Assay (ELISA) analyzer ... is a dedicated EVO platform for reliableELISA ... and incubation units operated by the new ... available in three sizes - 100, 150, ...
Biology Products: